Product portfolio

RU-58841 is a non-steroidal anti-androgen developed for topical use. It competitively binds to androgen receptors in the skin and hair follicles, blocking dihydrotestosterone (DHT) without systemic hormonal effects.

Ipamorelin is a pentapeptide and a selective agonist of the ghrelin/growth hormone secretagogue receptor. It is recognized for its ability to stimulate growth hormone (GH) secretion without significantly affecting prolactin, ACTH, or cortisol levels, making it one of the most targeted secretagogues available.

MK-677 (Ibutamoren) is an orally active, non-peptide growth hormone secretagogue that binds to the ghrelin receptor (GHS-R1a). It stimulates the release of growth hormone and IGF-1, modulating multiple metabolic and signaling pathways involved in tissue growth, repair, and overall endocrine regulation.

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that stimulates growth hormone secretion via the ghrelin receptor. It is one of the earliest and most studied GH secretagogues, notable for its pronounced appetite-stimulating effects.

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of the first 29 amino acids of the 44-amino acid native GHRH. It stimulates the pituitary to produce and secrete growth hormone in a physiologically natural pulsatile pattern.

Tesamorelin is a stabilized synthetic analog of GHRH with a trans-3-hexenoic acid modification. It is the only GHRH analog FDA-approved for reducing excess abdominal fat in HIV-associated lipodystrophy.

CJC-1295 (no DAC) is a modified GHRH analog consisting of 30 amino acids with amino acid substitutions to improve metabolic stability. Without the Drug Affinity Complex, it provides shorter-acting GH pulses that more closely mimic natural release.

CJC-1295 DAC is a long-acting GHRH analog conjugated with a Drug Affinity Complex that binds to serum albumin, extending its half-life to 6-8 days. It provides sustained, elevated GH and IGF-1 levels with less frequent dosing.

Semaglutide is a long-acting GLP-1 receptor agonist with 94% homology to native human GLP-1. It features a C-18 fatty diacid chain enabling albumin binding, resulting in a half-life of approximately 7 days and once-weekly dosing.

Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist. By simultaneously activating both incretin receptor pathways, it achieves superior glycemic control and weight loss compared to selective GLP-1 agonists.

Liraglutide is a GLP-1 receptor agonist with 97% homology to human GLP-1. A C-16 fatty acid (palmitic acid) attached via a glutamic acid spacer enables albumin binding, extending its half-life to 13 hours for once-daily dosing.

Cardarine (GW-501516) is an orally active, non-steroidal metabolic modulator that selectively binds to the PPARδ (Peroxisome Proliferator-Activated Receptor delta). It regulates the expression of genes involved in fatty acid metabolism, energy expenditure, and oxidative capacity in skeletal muscle.

GW-0742 is a highly selective PPARδ agonist structurally related to Cardarine (GW-501516). It demonstrates superior receptor selectivity and has been researched for its effects on lipid metabolism, inflammation, and endurance.

AOD9604 is a synthetic analog of the fat-burning segment of human Growth Hormone (hGH). It was specifically developed to retain the lipolytic (fat-reducing) properties of hGH without the undesired growth-promoting or insulin-resistance-inducing effects of the full molecule.

GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. It is renowned for its diverse biological actions, including promoting wound healing, attracting immune cells, and stimulating collagen and glycosaminoglycan synthesis in skin fibroblasts.

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that acts as a potent agonist of the ghrelin receptor. It is extensively researched for its ability to stimulate the pituitary gland to release natural growth hormone (GH) via the G-protein coupled receptor pathway.

Hexarelin is a synthetic hexapeptide growth hormone secretagogue (GHS) that possesses potent GH-releasing activity. It is highly valued in clinical research for its metabolic stability and its secondary effects on cardiovascular function through the activation of the CD36 receptor.

Retatrutide (LY3437943) is a cutting-edge, unimolecular triple receptor agonist. It targets the GLP-1, GIP, and glucagon (GCG) receptors, offering unprecedented potential in research involving weight management and metabolic health.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein. It is widely studied for its regenerative properties across multiple tissue types including muscle, tendon, ligament, and gut epithelium.

TB-500 is a synthetic version of the naturally occurring 43-amino acid peptide Thymosin Beta-4. It plays a central role in tissue repair, cell migration, and anti-inflammatory signaling, with applications across wound healing, cardiac repair, and musculoskeletal recovery research.

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist. It is the only melanocortin-based peptide FDA-approved for treating hypoactive sexual desire disorder, acting centrally on the nervous system rather than the vascular system.

Melanotan II is a synthetic cyclic lactam analog of alpha-melanocyte-stimulating hormone (α-MSH). It activates melanocortin receptors to stimulate melanogenesis, reduce appetite, and modulate sexual function, making it a multi-target peptide in research.

Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, with an added Pro-Gly-Pro sequence for enhanced stability. It is researched for its anxiolytic, nootropic, and immunomodulatory properties.

Semax is a synthetic heptapeptide derived from ACTH(4-7) with an attached Pro-Gly-Pro group. It is a potent nootropic and neuroprotective peptide that enhances cognitive function, memory, and attention without hormonal side effects.

Epithalon is a synthetic tetrapeptide based on the natural pineal gland peptide Epithalamin. It is primarily researched for its ability to activate telomerase, the enzyme responsible for maintaining telomere length, with implications for aging and cellular longevity.

DSIP is a naturally occurring nonapeptide that modulates sleep architecture, stress response, and neuroendocrine function. It promotes delta-wave (deep) sleep without acting as a sedative, preserving normal sleep-wake transitions.

IGF-1 LR3 is a modified 83-amino acid analog of human Insulin-like Growth Factor-1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. These modifications increase its half-life and reduce IGF binding protein affinity.

IGF-1 DES is a truncated 67-amino acid form of IGF-1 missing the first three N-terminal amino acids. This modification eliminates IGFBP binding, making it the most bioavailable and potent form of IGF-1 available for research.

MGF is a splice variant of IGF-1 produced locally in muscle tissue in response to mechanical stress. It activates satellite cells and initiates muscle repair, making it a key research compound for understanding exercise-induced hypertrophy.

PEG-MGF is a PEGylated form of Mechano Growth Factor with a polyethylene glycol moiety attached to increase systemic half-life. This modification extends its duration of action from minutes to hours, enabling systemic distribution.

Gonadorelin is a synthetic decapeptide identical to endogenous gonadotropin-releasing hormone (GnRH). It stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), playing a central role in reproductive endocrinology.

Triptorelin is a synthetic GnRH agonist decapeptide with a D-Trp substitution at position 6 that confers enhanced potency and enzymatic resistance. It is used in research and clinical settings for modulation of the HPG axis.

Oxytocin is a naturally occurring cyclic nonapeptide hormone produced in the hypothalamus. It regulates social bonding, reproduction, childbirth, and lactation, and is extensively studied for its roles in neurobehavioral and cardiovascular research.

LL-37 is the only human cathelicidin antimicrobial peptide. This 37-amino acid peptide plays a critical role in innate immunity, exhibiting broad-spectrum antimicrobial activity, immunomodulation, and wound healing properties.

Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from thymic tissue. It is a potent immunomodulator that enhances T-cell maturation, dendritic cell function, and cytokine production, with approved clinical use in over 35 countries.

Dihexa is a synthetic hexapeptide analog of angiotensin IV with extraordinary nootropic potency. It is approximately 10 million times more potent than BDNF at promoting hepatocyte growth factor (HGF) signaling and synaptogenesis.

SNAP-8 is a synthetic octapeptide that mimics the N-terminal end of SNAP-25, a protein involved in SNARE complex formation. By competing with native SNAP-25, it modulates neuromuscular junction signaling, making it a research tool in cosmeceutical and neuroscience applications.

Kisspeptin-10 is a truncated C-terminal decapeptide of the kisspeptin family that activates the GPR54/KISS1R receptor. It is a master upstream regulator of the HPG axis, directly controlling GnRH neuron firing and gonadotropin release.

VIP is a 28-amino acid neuropeptide that functions as a vasodilator, immunomodulator, and neurotransmitter. It regulates smooth muscle relaxation, exocrine secretion, and circadian rhythm, with broad research applications across multiple organ systems.

SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide that selectively concentrates in the inner mitochondrial membrane. It stabilizes cardiolipin, optimizes electron transport chain function, and reduces mitochondrial ROS production.

MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded by the 12S rRNA gene of mitochondrial DNA. It regulates metabolic homeostasis by activating AMPK and enhancing glucose and fatty acid metabolism.

Humanin is a 24-amino acid mitochondrial-derived peptide with potent cytoprotective and neuroprotective properties. It was discovered through its ability to suppress neuronal cell death induced by Alzheimer's disease-related genes.

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme essential to every living cell. It is a central mediator of energy metabolism, DNA repair, gene expression, and cellular signaling, with declining levels strongly correlated with aging.

Follistatin 344 is the full-length recombinant form of human follistatin, a glycoprotein that binds and neutralizes activin and myostatin. By inhibiting these TGF-β superfamily members, it removes natural brakes on muscle growth.

SR-9009 (Stenabolic) is a synthetic Rev-ErbA agonist that modulates circadian rhythm biology. It influences metabolic gene expression, fatty acid and glucose metabolism, and mitochondrial biogenesis in skeletal muscle.

SR-9011 is a second-generation Rev-ErbA agonist with improved potency and pharmacokinetic properties compared to SR-9009. It modulates circadian gene expression and enhances metabolic activity in muscle and adipose tissue.

Andarine (S-4) is an orally active, non-steroidal Selective Androgen Receptor Modulator (SARM) that binds to androgen receptors (AR) with high selectivity. It stimulates anabolic signaling pathways, promoting lean muscle growth, enhancing bone density, and supporting strength gains, while minimizing androgenic activity in non-target tissues.

Ostarine (MK-2866 / Enobosarm) is an orally active, non-steroidal Selective Androgen Receptor Modulator (SARM) that binds to androgen receptors (AR) with high selectivity. It promotes lean muscle growth, enhances bone density, and supports strength gains, while minimizing androgenic activity in non-target tissues.

Testolone (RAD-140) is an orally active, non-steroidal Selective Androgen Receptor Modulator (SARM) that selectively binds to androgen receptors (AR) in muscle and bone tissue. It promotes muscle growth, strength, and bone density, while minimizing androgenic effects on non-target tissues.

RAD-150 is an orally active, non-steroidal SARM and an esterified derivative of RAD-140. Its esterified form is designed for extended half-life and more stable blood levels, which may allow for less frequent dosing compared to RAD-140.

LGD-4033 (Ligandrol) is an orally active, non-steroidal SARM that binds to androgen receptors with high affinity and selectivity. It is one of the most widely researched SARMs for its potent anabolic effects on muscle and bone tissue with minimal impact on the prostate.

LGD-3303 is an orally bioavailable, non-steroidal SARM developed by Ligand Pharmaceuticals. It demonstrates potent and full agonist activity on muscle and bone androgen receptors while maintaining tissue selectivity over reproductive organs.

S-23 is an orally active, non-steroidal SARM with one of the highest binding affinities to androgen receptors among the SARM class. It has been investigated as a potential male hormonal contraceptive due to its potent suppression of spermatogenesis.

AC-262536 is a non-steroidal SARM that acts as a partial agonist of the androgen receptor. It offers moderate anabolic activity with significantly reduced androgenic effects, making it a subject of interest for milder research applications.

ACP-105 is a partial agonist SARM developed by Acadia Pharmaceuticals. It displays potent anabolic effects on muscle tissue while exerting minimal activity on the prostate, offering a high degree of tissue selectivity.

YK11 is a synthetic steroidal selective androgen receptor modulator (SARM) with unique myostatin-inhibiting properties. Its dual mechanism enhances anabolic activity, potentially supporting increased lean muscle mass, strength, and recovery beyond that of traditional SARMs.